Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hogg

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Cancer|November 6, 2004
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control studyJoni L Rutter, Christina M Bromley, Alisa M Goldstein, et al.
The Lancet. Oncology|November 9, 2002
Genetic testing for melanomaRichard Kefford, Julia Newton Bishop, Margaret Tucker, et al.
The Journal of Investigative Dermatology|April 8, 2021
Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor‒Like MelanomaThiago P Muniz, Hadas Sorotsky, Yada Kanjanapan, et al.
Journal for Immunotherapy of Cancer|January 23, 2021
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapyApril A N Rose, Susan M Armstrong, David Hogg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)Jason J Luke, Daniel J Olson, Jacob B Allred, et al.
Cancer|May 19, 2012
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trialAndrew J Wagner, John M Goldberg, Steven G Dubois, et al.
Oncogene|September 26, 2003
Germline splicing mutations of CDKN2A predispose to melanomaJoanne C Y Loo, Ling Liu, AiHua Hao, et al.
American Journal of Medical Genetics. Part A|March 11, 2005
Retrospective family study of childhood medulloblastomaDavid Ng, Theodora Stavrou, Ling Liu, et al.
Cancer Medicine|March 3, 2020
Cancer patients' experiences with immune checkpoint modulators: A qualitative studyKari Ala-Leppilampi, Natalie A Baker, Chris McKillop, et al.
Melanoma Research|November 10, 2020
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic targetRiyue Bao, Oliver Surriga, Daniel J Olson, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Cancer|November 6, 2004
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control studyJoni L Rutter, Christina M Bromley, Alisa M Goldstein, et al.
The Lancet. Oncology|November 9, 2002
Genetic testing for melanomaRichard Kefford, Julia Newton Bishop, Margaret Tucker, et al.
The Journal of Investigative Dermatology|April 8, 2021
Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor‒Like MelanomaThiago P Muniz, Hadas Sorotsky, Yada Kanjanapan, et al.
Journal for Immunotherapy of Cancer|January 23, 2021
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapyApril A N Rose, Susan M Armstrong, David Hogg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)Jason J Luke, Daniel J Olson, Jacob B Allred, et al.
Cancer|May 19, 2012
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trialAndrew J Wagner, John M Goldberg, Steven G Dubois, et al.
Oncogene|September 26, 2003
Germline splicing mutations of CDKN2A predispose to melanomaJoanne C Y Loo, Ling Liu, AiHua Hao, et al.
American Journal of Medical Genetics. Part A|March 11, 2005
Retrospective family study of childhood medulloblastomaDavid Ng, Theodora Stavrou, Ling Liu, et al.
Cancer Medicine|March 3, 2020
Cancer patients' experiences with immune checkpoint modulators: A qualitative studyKari Ala-Leppilampi, Natalie A Baker, Chris McKillop, et al.
Melanoma Research|November 10, 2020
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic targetRiyue Bao, Oliver Surriga, Daniel J Olson, et al.
Pageof 8